Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition

American Journal of Epidemiology

Volumn 167, Issue 4, 2008, Pages 438-446

  Weikert, Steffen ^a,b   Boeing, Heiner ^a   Pischon, Tobias ^a   Weikert, Cornelia ^a   Olsen, Anja ^c   Tjonneland, Anne ^c   Overvad, Kim ^d   Becker, Nikolaus ^e   Linseisen, Jakob ^e   Trichopoulou, Antonia ^f   Mountokalakis, Theodore ^f   Trichopoulos, Dimitrios ^g   Sieri, Sabina ^h   Palli, Domenico ⁱ   Vineis, Paolo ^j   Panico, Salvatore ^k   Peeters, Petra H M ^l   Bueno De Mesquita, H Bas ^m   Verschuren, W M Monique ^m   Ljungberg, Borje ⁿ   Hallmans, Goran ⁿ   Berglund, Goran ^o   González, Carlos A ^p   Dorronsoro, Miren ^q   Barricarte, Aurelio ^r   Tormo, M J ^s   Allen, Naomi ^t   Roddam, Andrew ^t   Bingham, Sheila ^u   Khaw, Kay Tee ^v   Rinaldi, Sabina ^w   Ferrari, Pietro ^w   Norat, Teresa ^w,x   Riboli, Elio ^x   more..

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^g HELLENIC HEALTH FOUNDATION   (Greece)

^h NATIONAL CANCER INSTITUTE   (Italy)

ⁱ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^j UNIVERSITY OF TURIN   (Italy)

^k UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁿ UMEÅ UNIVERSITY   (Sweden)

^o LUND UNIVERSITY   (Sweden)

^p CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^q Department of Public Health of Guipuzcoa ^*  (Spain)

^r INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^s DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^t UNIVERSITY OF OXFORD   (United Kingdom)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^w INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^x IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Antihypertensive agents; Hypertension; Kidney neoplasms; Risk factors

Indexed keywords

CANCER; DRUG; HYPERTENSION; NUTRITION; RISK FACTOR; TUMOR;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUTRITION; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TIME SERIES ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARCINOMA, RENAL CELL; COHORT STUDIES; DIET; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; LIFE STYLE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EURASIA; EUROPE;

EID: 39349107170     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm321     Document Type: Article

References (39)

1. Mathew A, Devesa SS, Fraumeni JF Jr, et al. Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 2002;11:171-8.
2. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA 1999;281:1628-31.
3. Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006;98:1331-4.
4. Levi F, Lucchini F, Negri E, et al. Declining mortality from kidney cancer in Europe. Ann Oncol 2004;15:1130-5.
5. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
6. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC Press, 2004.
7. Chow WH, Gridley G, Fraumeni JF Jr, et al. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000;343:1305-11.
8. Flaherty KT, Fuchs CS, Colditz GA, et al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control 2005;16:1099-106.
9. Fraser GE, Phillips RL, Beeson WL. Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-Day Adventists. Int J Epidemiol 1990;19:832-8.
10. Fryzek JP, Poulsen AH, Johnsen SP, et al. A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 2005;92:1302-6.
11. Grove JS, Nomura A, Severson RK, et al. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991;134:942-7.
12. Heath CW Jr, Lally CA, Calle EE, et al. Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol 1997;145:607-13.
13. Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer 2004;108:115-21.
14. Schouten LJ, van Dijk BA, Oosterwijk E, et al. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study. J Hypertens 2005;23:1997-2004.
15. Coughlin SS, Neaton JD, Randall B, et al. Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial. Cancer 1997;79:2171-7.
16. Shapiro JA, Williams MA, Weiss NS, et al. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol 1999;149:521-30.
17. Ferrari P, Kaaks R, Fahey MT, et al. Within- and between-cohort variation in measured macronutrient intakes, taking account of measurement errors, in the European Prospective Investigation into Cancer and Nutrition study. Am J Epidemiol 2004;160:814-22.
18. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26(suppl 1):S6-14.
19. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003;78(suppl):559S-69S.
20. Weikert S, Boeing H, Pischon T, et al. Fruits and vegetables and renal cell carcinoma: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006;118:3133-9.
21. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006;118:728-38.
22. Schulze MB, Kroke A, Saracci R, et al. The effect of differences in measurement procedure on the comparability of blood pressure estimates in multi-centre studies. Blood Press Monit 2002;7:95-104.
23. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
24. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
25. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6:356-65.
26. Rosenberg PS, Katki H, Swanson CA, et al. Quantifying epidemiologic risk factors using non-parametric regression: model selection remains the greatest challenge. Stat Med 2003;22:3369-81.
27. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23.
28. Benichou J, Chow WH, McLaughlin JK, et al. Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol 1998;148:424-30.
29. Messerli FH. Risk factors for renal cell carcinoma: hypertension or diuretics? Kidney Int 2005;67:774-5.
30. Yuan JM, Castelao JE, Gago-Dominguez M, et al. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 1998;77:1508-13.
31. Gago-Dominguez M, Castelao JE, Yuan JM, et al. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 2002;13:287-93.
32. 7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 1997;22:1019-27.
33. Toyokuni S, Uchida K, Okamoto K, et al. Formation of 4-hydroxy-2-nonenal- modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci U S A 1994;91:2616-20.
34. Haase VH. The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease. Kidney Int 2006;69:1302-7.
35. Welch WJ. Intrarenal oxygen and hypertension. Clin Exp Pharmacol Physiol 2006;33:1002-5.
36. Koshiji M, Kageyama Y, Pete EA, et al. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004;23:1949-56.
37. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev 2000;14:34-44.
38. Raval RR, Lau KW, Tran MG, et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005;25:5675-86.
39. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-17.